Cell Medica company

Cell Medica is a cell therapy company working on new techniques to cure human diseases based upon a treatment method called cellular immunotherapy. This technique involves harnessing and enhancing the power of the human immune system to fight disease.
Based on a number of academic studies, there is strong evidence that cellular immunotherapy can be used in a safe and effective manner to treat diseases ranging from infections to cancer.
Cell Medica is both an R&D company developing new forms of cell therapies and a cell production/processing company providing clinical-grade cell formulations to hospitals for the treatment of patients.
Technology: Regenerative Medicine
Industry: Personalized Medicine
Headquarters: London, England, United Kingdom
Founded Date: 2005
Employees Number: 11-50
Funding Status: Late Stage Venture
Investors Number: 7
Total Funding: $191.8M
Estimated Revenue: $1M to $10M
Last Funding Type: Series C

Visit Website
Register and Claim Ownership